239 related articles for article (PubMed ID: 11439735)
1. Rheumatoid arthritis: guidelines for emerging therapies.
Blumberg SN; Fox DA
Am J Manag Care; 2001 Jun; 7(6):617-26. PubMed ID: 11439735
[TBL] [Abstract][Full Text] [Related]
2. The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.
Cohen SB
Rheum Dis Clin North Am; 2004 May; 30(2):365-80, vii. PubMed ID: 15172046
[TBL] [Abstract][Full Text] [Related]
3. [Proposal for anti-TNFalpha therapy in adult patients with rheumatoid arthritis].
Curković B; Babić-Naglić D; Morović-Vergles J; Anić B; Grazio S
Reumatizam; 2007; 54(1):16-9. PubMed ID: 18450272
[TBL] [Abstract][Full Text] [Related]
4. [Current aspects of cost effectiveness of TNF-alpha blocking agents in patients with rheumatoid arthritis].
Merkesdal S; Ruof J
Z Rheumatol; 2002; 61 Suppl 2():II/29-32. PubMed ID: 12491120
[TBL] [Abstract][Full Text] [Related]
5. [New perspectives in the treatment of rheumatoid arthritis].
Martín Alcalde E; Cantero Blanco S; Sánchez García FJ; Gómez Castillo JJ
Farm Hosp; 2003; 27(6):360-70. PubMed ID: 14974882
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial outcome of anti-tumour necrosis factor alpha therapy in rheumatic arthritis.
Choy E
Cytokine; 2004 Nov 21-Dec 7; 28(4-5):158-61. PubMed ID: 15588689
[TBL] [Abstract][Full Text] [Related]
7. Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade: comment on the article by Buch et al.
Schiff MH
Arthritis Rheum; 2005 Jan; 52(1):364-5; author reply 365. PubMed ID: 15641081
[No Abstract] [Full Text] [Related]
8. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Cytokine antagonists].
Schnabel A; Gross WL
Dtsch Med Wochenschr; 2003 Jan; 128(5):201-3. PubMed ID: 12557112
[No Abstract] [Full Text] [Related]
9. Management of rheumatoid arthritis.
Handa R
Natl Med J India; 2004; 17(3):143-51. PubMed ID: 15253402
[TBL] [Abstract][Full Text] [Related]
10. Biologics in rheumatoid arthritis.
Sharma PK; Hota D; Pandhi P
J Assoc Physicians India; 2004 Mar; 52():231-6. PubMed ID: 15636315
[TBL] [Abstract][Full Text] [Related]
11. Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor alpha blockade: comment on the article by Buch et al.
Saxne T; Larsson L; Geborek P
Arthritis Rheum; 2004 Sep; 50(9):3049-50; author reply 3050-1. PubMed ID: 15457477
[No Abstract] [Full Text] [Related]
12. Anakinra: the first interleukin-1 inhibitor in the treatment of rheumatoid arthritis.
Kary S; Burmester GR
Int J Clin Pract; 2003 Apr; 57(3):231-4. PubMed ID: 12723729
[TBL] [Abstract][Full Text] [Related]
13. Immunological therapies for rheumatoid arthritis.
Edwards CJ
Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
[TBL] [Abstract][Full Text] [Related]
14. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
Baslund B; Bendtzen K
Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481
[TBL] [Abstract][Full Text] [Related]
15. Emerging biologic drugs for the treatment of rheumatoid arthritis.
Puppo F; Murdaca G; Ghio M; Indiveri F
Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092
[TBL] [Abstract][Full Text] [Related]
16. Biologic therapy for early rheumatoid arthritis: the latest evidence.
Castro-Rueda H; Kavanaugh A
Curr Opin Rheumatol; 2008 May; 20(3):314-9. PubMed ID: 18388524
[TBL] [Abstract][Full Text] [Related]
17. Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade.
Buch MH; Bingham SJ; Seto Y; McGonagle D; Bejarano V; White J; Emery P
Arthritis Rheum; 2004 Mar; 50(3):725-8. PubMed ID: 15022311
[TBL] [Abstract][Full Text] [Related]
18. The new era in the treatment of rheumatoid arthritis.
Putterman C
Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):2-4. PubMed ID: 17694188
[No Abstract] [Full Text] [Related]
19. Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005.
Furst DE; Breedveld FC; Kalden JR; Smolen JS; Burmester GR; Bijlsma JW; Dougados M; Emery P; Keystone EC; Klareskog L; Mease PJ
Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv2-14. PubMed ID: 16239380
[No Abstract] [Full Text] [Related]
20. Assessing the value of rheumatoid arthritis treatment alternatives: the potential effect of tumor necrosis factor inhibitors.
Mizutani W
Manag Care Interface; 2003 Mar; 16(3):44-50, 55. PubMed ID: 12715413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
